Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Sepriano

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
The Lancet. Rheumatology|January 24, 2024
Precision medicine in rheumatoid arthritis: unravelling sex-driven differences in response to treatmentAlexandre Sepriano, Elena Nikiphorou
Joint Bone Spine|September 28, 2025
Axial spondyloarthritis and polymyalgia rheumatica: When differential diagnosis is not that obviousMargarida Lucas Rocha, Sofia Ramiro, Alexandre Sepriano
Acta Reumatologica Portuguesa|September 9, 2016
Investigator initiated trials in Portuguese rheumatologyElsa Vieira Sousa, Alexandre Sepriano, Fernando Pimentel Santos
ARP Rheumatology|October 1, 2025
ARP Rheumatology 2020-2025: 5 years at a glanceAlexandre Sepriano, Daniela Santos-Faria, João Cavaleiro, et al.
Seminars in Arthritis and Rheumatism|January 13, 2024
Why most (but perhaps not all) DMARDs work equally wellRobert B M Landewé, Alexandre Sepriano, Sytske Anne Bergstra
ARP Rheumatology|May 28, 2022
Welcome to ARP RheumatologyAlexandre Sepriano, Daniela Santos-Faria, João Cavaleiro, et al.
RMD Open|June 7, 2019
Three handy tips and a practical guide to improve your propensity score modelsSytske Anne Bergstra, Alexandre Sepriano, Sofia Ramiro, et al.
Lancet (London, England)|January 11, 2025
Axial spondyloarthritisVictoria Navarro-Compán, Alexandre Sepriano, Dafne Capelusnik, et al.
RMD Open|July 13, 2021
Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inferenceAlexandre Sepriano, Sofia Ramiro, Desirée van der Heijde, et al.
Acta Reumatologica Portuguesa|January 18, 2014
Off-label use of rituximab in systemic rheumatic diseases: case series and reviewFilipe Araújo, Inês Silva, Alexandre Sepriano, et al.
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
The Lancet. Rheumatology|January 24, 2024
Precision medicine in rheumatoid arthritis: unravelling sex-driven differences in response to treatmentAlexandre Sepriano, Elena Nikiphorou
Joint Bone Spine|September 28, 2025
Axial spondyloarthritis and polymyalgia rheumatica: When differential diagnosis is not that obviousMargarida Lucas Rocha, Sofia Ramiro, Alexandre Sepriano
Acta Reumatologica Portuguesa|September 9, 2016
Investigator initiated trials in Portuguese rheumatologyElsa Vieira Sousa, Alexandre Sepriano, Fernando Pimentel Santos
ARP Rheumatology|October 1, 2025
ARP Rheumatology 2020-2025: 5 years at a glanceAlexandre Sepriano, Daniela Santos-Faria, João Cavaleiro, et al.
Seminars in Arthritis and Rheumatism|January 13, 2024
Why most (but perhaps not all) DMARDs work equally wellRobert B M Landewé, Alexandre Sepriano, Sytske Anne Bergstra
ARP Rheumatology|May 28, 2022
Welcome to ARP RheumatologyAlexandre Sepriano, Daniela Santos-Faria, João Cavaleiro, et al.
RMD Open|June 7, 2019
Three handy tips and a practical guide to improve your propensity score modelsSytske Anne Bergstra, Alexandre Sepriano, Sofia Ramiro, et al.
Lancet (London, England)|January 11, 2025
Axial spondyloarthritisVictoria Navarro-Compán, Alexandre Sepriano, Dafne Capelusnik, et al.
RMD Open|July 13, 2021
Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inferenceAlexandre Sepriano, Sofia Ramiro, Desirée van der Heijde, et al.
Acta Reumatologica Portuguesa|January 18, 2014
Off-label use of rituximab in systemic rheumatic diseases: case series and reviewFilipe Araújo, Inês Silva, Alexandre Sepriano, et al.
Pageof 13